Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasiglucagon for prevention of insulin-induced hypoglycemia in type 1 diabetes
NCT04449692Phase 2Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Jul 2020
- Primary completion
- Jan 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dasiglucagon in hypoglycemia, sponsored by Steno Diabetes Center Copenhagen. Started Jul 2020; status: completed.
02
Drugs
dasiglucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT04449692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04449692.